| Overview |
| bsm-90021r-50µL |
| Peroxiredoxin 1 Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human, Mouse |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human PRDX1 |
| 1-52/199 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 5052 |
| Q06830 |
| PRDX1; Peroxiredoxin 1; NKEFA; PAGA; Thioredoxin-Dependent Peroxide Reductase; Natural Killer Cell-Enhancing Factor A; Proliferation-Associated Gene Protein; Thioredoxin-Dependent Peroxiredoxin 1; Thioredoxin Peroxidase; Peroxiredoxin-1; NKEF-A; TDPX2; PAGB; PAG; Epididymis Secretory Sperm Binding Protein; Natural Killer-Enhancing Factor A; Proliferation-Associated Gene A; EC 1.11.1.24; EC 1.11.1.15; EC 1.11.1; MSP23; PRX1; PRXI |
| Cell Line: HeLa Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |